For the quarter ending 2026-03-31, KOD had -$40,332K decrease in cash & cash equivalents over the period. -$40,951K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net accretion of discount on marketable securities | - | 0 | - | - |
| Settlement of derivative contracts | - | 0 | 0 | 0 |
| Net loss | -58,158 | -56,736 | -61,457 | -111,774 |
| Depreciation | 4,109 | 4,544 | 4,587 | 9,197 |
| Stock-based compensation | 12,155 | 13,285 | 14,046 | 31,532 |
| Loss on disposal of long-lived assets | 8 | - | 0 | -8 |
| Non-cash lease impairment expense | 0 | 0 | 0 | 1,910 |
| Amortization of operating lease right-of-use asset | 2,231 | 1,971 | 1,952 | 4,069 |
| Adjustment to reconcile net income to cash provided by (used in) operating activity, other item | - | 20 | - | - |
| Prepaid expenses and other current assets | 975 | 1,063 | -64 | -108 |
| Other assets | 8 | -6 | 15 | -68 |
| Accounts payable | -733 | 1,626 | 5,315 | 1,129 |
| Accrued and other current liabilities | 4,558 | -2 | 5,639 | 3,636 |
| Operating lease liability | -3,188 | -3,021 | -3,011 | -5,133 |
| Long-term deposit | 0 | 0 | 0 | 1,500 |
| Net cash used in operating activities | -40,009 | -39,378 | -32,880 | -63,750 |
| Purchase of property and equipment | 942 | 43 | 60 | 403 |
| Deposits on property and equipment | - | 0 | 0 | - |
| Purchase of marketable securities | - | 0 | - | - |
| Maturities of marketable securities | - | 0 | - | - |
| Settlement of derivative contracts | - | 0 | 0 | 0 |
| Net cash used in investing activities | -942 | -43 | -60 | -403 |
| Proceeds from public offering, net of underwriting discount | - | 172,960 | - | - |
| Payment of public offering costs | 303 | - | - | - |
| Proceeds from stock option exercises | 922 | 4,187 | 813 | 162 |
| Proceeds from espp | - | 98 | 0 | 82 |
| Principal payments of tenant improvement allowance payable | - | 0 | - | - |
| Net cash provided by financing activities | 619 | 177,245 | 813 | 244 |
| Net decrease in cash, cash equivalents and restricted cash | -40,332 | 137,824 | -32,127 | -63,909 |
| Cash, cash equivalents and restricted cash, at beginning of period | 216,046 | 78,222 | 174,258 | - |
| Cash, cash equivalents and restricted cash, at end of period | 175,714 | 216,046 | 78,222 | - |
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)